There were 1,160 press releases posted in the last 24 hours and 442,118 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Kura Oncology’s Menin-MLL Inhibitor KO-539 Receives Orphan Drug Designation from FDA for Treatment of Acute Myeloid Leukemia

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image